Malaga Cove Capital’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-22,616
Closed -$1.58M 180
2021
Q3
$1.58M Sell
22,616
-112
-0.5% -$7.87K 0.65% 50
2021
Q2
$1.56M Sell
22,728
-1,209
-5% -$80.7K 0.67% 52
2021
Q1
$1.55M Sell
23,937
-485
-2% -$31.3K 0.66% 53
2020
Q4
$1.43M Sell
24,422
-718
-3% -$43.3K 0.67% 51
2020
Q3
$1.59M Buy
25,140
+327
+1% +$22.7K 0.93% 26
2020
Q2
$1.91M Buy
24,813
+143
+0.6% +$11K 1.17% 16
2020
Q1
$1.84M Buy
24,670
+6,063
+33% +$419K 1.51% 8
2019
Q4
$1.21M Buy
18,607
+3,069
+20% +$200K 0.75% 41
2019
Q3
$985K Sell
15,538
-752
-5% -$49.2K 0.67% 54
2019
Q2
$1.1M Buy
16,290
+2,400
+17% +$158K 0.71% 37
2019
Q1
$903K Sell
13,890
-103
-0.7% -$6.85K 0.55% 56
2018
Q4
$871K Buy
13,993
+6,806
+95% +$476K 0.6% 51
2018
Q3
$563K Buy
7,187
+178
+3% +$13.4K 0.31% 98
2018
Q2
$497K Buy
+7,009
New +$495K 0.25% 104

Other funds holding GILD

Malaga Cove Capital's GILD Position: Q4 2021 in Review

Malaga Cove Capital sold out of Gilead Sciences (GILD) in Q4 2021, closing a stake of 22,616 shares — an estimated $1.58M sold.

Malaga Cove Capital first reported a position in GILD in Q2 2018 and held it in 14 quarters. The position peaked at $1.91M in Q2 2020. 1,682 funds tracked by Wall St. Rank hold GILD as of Q4 2021.

  • Malaga Cove Capital reported no remaining Gilead Sciences position as of Q4 2021 after selling out during the quarter.
  • Malaga Cove Capital sold 22,616 Gilead Sciences shares in Q4 2021, an estimated $1.58M.
  • Malaga Cove Capital first reported a position in Gilead Sciences in Q2 2018 and held it in 14 quarters.
  • Malaga Cove Capital's Gilead Sciences position peaked at $1.91M in Q2 2020.
  • 1,682 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2021.

Based on Malaga Cove Capital's 13F filing for Q4 2021, filed 10 Feb 2022.